Stage IV Cutaneous Melanoma AJCC v6 and v7 Active Not Recruiting Phase 2 Trials for Rasdegafusp alfa (DB15185)

IndicationStatusPhase
DBCOND0091050 (Stage IV Cutaneous Melanoma AJCC v6 and v7)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02129075CDX-1401 and Poly-ICLC Vaccine Therapy With or Without CDX-301 in Treating Patients With Stage IIB-IV MelanomaTreatment